Insulet Launches its Omnipod DASH Insulin Management System in Europe

Omnipod DASH in Europe
Image: Omnipod

Insulet, a maker of wearable Insulin Management System, based in Massachusetts, announced the launch of its Omnipod DASH™ Insulin Management System in the United Kingdom and the Netherlands. People with diabetes at King’s College Hospital in London and a leading hospital in Amsterdam are now among the first in Europe to access Insulet’s new system.

Designed to be used by individuals of all ages, the tubeless Omnipod DASH System is simple and easy to use. It provides up to three days of non-stop insulin delivery, without the need for daily injections and allows users to discreetly manage their diabetes via a new touchscreen interface, reports Business Wire.

“King’s is proud to be one of the first centers to offer the Omnipod DASH System in Europe, which will help expand choice available for people with diabetes, including those on Multiple Daily Injections who are using or considering the use of insulin pump therapy,” said Dr Pratik Choudhary, Senior Lecturer and Consultant in Diabetes at King’s College London. “The system is so intuitive and easy to use that it allows us as Healthcare Professionals to focus more of our time with our patients rather than the technology.”

A man and a child cooking
Image: Omnipod

The Omnipod DASH System received FDA clearance in June 2018, and CE marking in September 2019.

Insulet recently won ‘Medical Device Company of the Year’ at the prestigious Diabetes Professional Conference in October 2019, London in recognition for excellence in launching direct operations in Europe since July 1st 2018.

“We are highly focused on individualized care and freedom of choice, both of which are exceptionally important when it comes to the overall customer experience,” said DJ Cass, General Manager, Europe, Insulet Corporation. “Our customers were at the heart of our development efforts when designing our new product innovation and we are proud to build on the existing advantages of Pod therapy, which provides flexibility, ease of use and discretion.”

Read more FDA Authorizes Tandem’s Interoperable, Automated Insulin Dosing Controller

The Omnipod DASH System consists of two components: a tubeless, waterproof, Bluetooth enabled Pod that holds up to 200 units of insulin and a modern, color touch-screen Personal Diabetes Manager (PDM) that controls the Pod.

Previous articleNeurable Raises $6 Million to Build Intuitive, User-Friendly Neurotechnology Products
Next articleAmerican Diabetes Association Recognizes Use of Autonomous AI for Diabetes Care
Sam Draper
Sam Draper () is Online Editor at WT | Wearable Technologies specialized in the field of sports and fitness but also passionated about any new lifestyle gadget on the market. Sam can be contacted at press(at)